Contact A Counsellor

counsellor button


Research on Depression in the Workplace.

For more information please click here



To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here


Mental Health Matters Journal for Psychiatrists & GP's

Vol6Issue1Cover 200x300

Click here for more info on articles & how to subscribe


4 wpcf 300x300

Literacy is a luxury that many of us take for granted.  We depend on written communication for information, guidance, and access to heath care information That is why SADAG created SPEAKING BOOKS and revolutionized the way information is delivered to low literacy communities. It's exactly what it sounds like.a book that talks to the reader in his or her local  language, delivering critical information in an interactive, and educational way.

The customizable 16-page book, accompanied by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood..

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 30 titles, such as TB, Malaria, Polio, Vaccines for over 30 countries.

suicide speaking book

Electroconvulsive therapy (ECT) remains one of the most effective treatments we have to treat depression. Acute response rates for ECT are consistently higher than response rates generally reported in clinical trials for antidepressant medications. This observation is doubly impressive knowing that patients who today receive ECT for an index episode of depression typically have failed 2 or more antidepressant medication trials.

The bipolar pharmacopoeia has steadily increased over the past 10 years. The US Food and Drug Administration (FDA) has approved 10 treatments for mania, 4 treatments for the maintenance phase of bipolar disorder, and 2 for bipolar depression. With these substantial clinical advances, it is often forgotten how effective ECT is for bipolar depression, depression with a switch into mania (ECT treatment through the mania), refractory mania, and maintenance ECT for bipolar disorder. Although it would be difficult to study with a controlled comparative design, many clinicians think that ECT is still the best mood stabilizer we have to date. Given the need for anesthesia and the potential for cognitive deficits as a side effect, ECT for bipolar depression, as with unipolar depression, has been viewed less as first-line agent and thus reserved for refractory cases.

However, ECT may be the treatment of choice for bipolar mania or depression in pregnancy to avoid potential teratogenicity related to pharmacotherapy. In addition, for bipolar patients with a compromised nutritional status who acutely become catatonic or severely depressed, and the delay of several weeks for antidepressant response is not an option, ECT would be a first-line agent. For a review of these data, see Bonds and colleagues.


Our Sponsors

Our Partners